Notice of Annual Meeting of Shareholders 2020

AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand
Incorporated in New Zealand ARBN 609 017 969



Notice of Annual Meeting of Shareholders 2020


Notice is hereby given that the Annual Meeting of shareholders of AFT Pharmaceuticals Limited (AFT or
the Company) will be held at the Milford Cruising Club, 24 Craig Road, Milford, Auckland, New Zealand,
on Wednesday, 12 August 2020 commencing at 10.30am (New Zealand time).

Agenda

A Addresses

Our Chair, David Flacks, and our Founder and Chief Executive Officer, Hartley Atkinson, will provide
an overview of the Company’s performance for the year ended 31 March 2020. There will also be
an opportunity for shareholders to ask questions.

B Resolutions

Shareholders will be asked to consider, and if thought fit, pass the following ordinary resolutions:

1. That the directors are authorised to fix the fees and expenses of Deloitte as
auditor for the 2021 financial year.

2. That Ms Marree Atkinson be re-elected as a director of AFT Pharmaceuticals Limited.

Resolutions 1 and 2 are ordinary resolutions and must be approved by a simple majority of the
votes of those shareholders entitled to vote and voting on the resolutions.


See explanatory notes on each of these resolutions below. No shareholder is restricted from voting
on resolutions 1 and 2.

The Board recommends unanimously that you vote in favour of all resolutions.

C General Business

To consider any other matter that may be brought properly before the Annual Meeting.


By Order of the AFT Pharmaceuticals Limited Board




David Flacks
Chairman

15 July 2020

Page | 2

Explanatory Notes


Resolution 1: Auditor’s Remuneration
Deloitte is automatically reappointed auditor of
the Company at the Annual Meeting pursuant
to the Companies Act 1993. The resolution
sought is to authorise the directors to fix the
remuneration of the auditor pursuant to section
207(S)(a) of the Companies Act 1993.
Resolution 2: Re-election of Ms Marree Atkinson
as a Director
Marree was appointed as a director by the
shareholders of AFT on 4 September 2012, and
was last re-elected in 2017. In accordance with
the applicable NZX listing rules, Marree retires by
rotation and offers herself for re-election as a
director of AFT at the meeting. The Board
unanimously supports Marree's re-election and
considers Marree to be a non-independent
director.
Marree Atkinson
Executive Director
Marree has been involved in all aspects of AFT’s
business since its establishment in 1997,
including roles in sales, regulatory affairs,
customer services and logistics. Marree’s role as
Chief of Staff sees her involved in the
day-to-day running of AFT’s head office
including managing staffing requirements and
special projects involving AFT’s head and
affiliate offices. Marree is a registered nurse
previously practising at Waikato Hospital.

Page | 3

Important Information



Attendance at Meeting
All shareholders registered on the Company’s
share register at the date of the meeting are
entitled to attend and vote at the meeting.
Voting and Proxies
Voting at the meeting shall be by way of a poll
of the Company's shareholders entitled to vote
and voting.
A shareholder entitled to attend and vote at
the meeting can appoint a proxy to attend and
vote on their behalf. A proxy need not be a
shareholder. The Chair of the meeting may be
appointed to act as proxy.
If the Chair of the meeting is appointed to act
as proxy and is not directed how to vote, the
Chair will vote in favour of all the resolutions.
If you do not name a person as your proxy or
your named proxy does not attend the
meeting, the Chairman will be appointed your
proxy and may only vote in accordance with
your express direction.
A shareholder wishing to appoint a proxy can
do so by visiting
www.investorvote.co.nz.
Holders will be required to enter their
CSN/Holder Number and postcode or country
of residence to complete the online
appointment.
Alternatively, shareholders can appoint a proxy
by completing the enclosed proxy form and
returning it to Computershare Investor Services
Limited by any of the methods specified on the
proxy form.
The proxy form must be received no later than
10.30am on Monday 10 August 2020 (being 48
hours prior to the meeting).




Webcast

The Annual Meeting will be webcast live. To view
and listen to the webcast, please visit
http://www.openbriefing.com/OB/3821.aspx.

Note that shareholders joining by webcast will
not be able to vote at the meeting or ask
questions. In order to vote you will need to
appoint a proxy in accordance with the above
instructions before 10.30am on Monday
10 August 2020.

If you have any questions you would like
considered at the meeting, please send them to
investor.relations@aftpharm.com
in advance of
the meeting.
More Information
If you have any questions, or for more
information, please contact AFT’s Company
Secretary, at investor.relations@aftpharm.com